Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Huitian Bio-Pharma is a large, comprehensive pharmaceutical company with over 80 drug specifications across seven dosage forms. Its portfolio includes national exclusive varieties and state-class new drugs. The company has both innovative and generic products on the market, including one state secret recipe, four national exclusive varieties, one Class I state new drug, one Class II state new drug, and two Class III state new drugs. Notable products include treatments for tinea diseases and Tripterygium lactone ointment. The aminoglycoside G418 product is mainly for export.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fujian Huitianhuakai Biotech.